ALKBH5 and neoplasm: Concordantly, 5-FU or Oxaliplatin in combination with ALKBH5 cKO most effectively inhibited cell proliferation (Fig. 8C), together with drastic down-regulation of β-catenin in tumor tissues (Fig. 8D).